Newer molecular methods constitute powerful tools for identifying outbreaks and tracing contacts in studies of infectious diseases. In the early 1990s, IS*6110* restriction fragment length polymorphism (RFLP) became the standard typing method for tuberculosis (TB) epidemiology.[@b1-asm-2-102] IS*6110*, used as a probe for RPLP, is an insertion sequence containing 1.355-base pairs. It is present in different copy numbers (between 0 and 25 copies) in the *Mycobacterium tuberculosis* complex and is located at various chromosomal sites.[@b2-asm-2-102],[@b3-asm-2-102] A DNA fingerprinting method based on the IS*6110-*RFLP has been used widely to type *M. tuberculosis* isolates in epidemiologic studies of TB. IS*6110* results are stable and reproducible, and have a high discriminatory power. Therefore, IS*6110* is useful for population-based epidemiologic studies and the control of laboratory cross-contamination.[@b4-asm-2-102],[@b5-asm-2-102] However, it is widely recognized that strains with low copy numbers (fewer than six) show little polymorphism, and identical patterns are commonly found for strains from apparently unconnected patients.[@b6-asm-2-102] A second probe, referred to as pTBN12, is useful for fingerprinting mycobacteria. This recombinant plasmid contains an insert characterized as a polymorphic GC-rich repetitive sequence. The polymorphic GC-rich repetitive sequence is a short sequence that is repeated multiple times in the genomes of *M. tuberculosis* and other mycobacteria. It has proven useful in distinguishing *M. tuberculosis* strains with fewer than six copies of IS*6110*.[@b4-asm-2-102]

The aim of this study was to determine the epidemiological relationship between rifampin-resistant *M. tuberculosis* strains isolated from different patients in the Aegean region of Turkey. We also intended to obtain information about the origin and transmission of the drug-resistant strains and the efficiency of regional control programs.

Methods
=======

The 26 clinical *M. tuberculosis* isolates used in this study came from 26 different patient sputum samples from the Regional Tuberculosis Laboratory and Ege University Mycobacteriology Laboratory, Izmir, Turkey. Previously, rpoB mutations and antituberculosis susceptibilities had been determined by DNA sequencing and proportional methods.[@b7-asm-2-102] The critical concentrations for defining resistance to rifampin, isoniazid, streptomycin, and ethambutol were 1 μg/mL, 0.2 μg/mL, 2 μg/mL and 5 μg/mL, respectively.[@b8-asm-2-102] Patient data were collected from the records of the laboratories. If necessary, additional data were obtained from the clinicians.

Molecular typing was performed at the Inonu University Molecular Microbiology Laboratory, Malatya, Turkey, using the IS*6110* and pTBN12-RFLP methods. Two micrograms of genomic DNA was digested with PvuII. Restriction fragments were separated by gel electrophoresis and transferred to a nylon membrane. DNA fragments were detected with a IS*6110* probe.[@b1-asm-2-102] Isolates with copy numbers less than six were typed by use of a pTBN12 probe. Genomic DNA was restricted by AluI. Restriction fragments were separated by gel electrophoresis and transferred to a nylon membrane. DNA fragments were detected with a chemoluminescent-labeled pTBN12 probe.[@b9-asm-2-102]

Isolates were considered in the same cluster if they met any one of the following criteria: (i) a copy number of six or greater with identical IS*6110-*RFLP patterns, (ii) a copy number of six or greater with only one banding pattern that differed and which had the same pTBN12 fingerprinting pattern, (iii) a copy number below six but with identical banding patterns by both methods.[@b10-asm-2-102]

Results
=======

The drug susceptibility patterns and rifampin-resistance genotypes of the 26 *M. tuberculosis* isolates are shown in [Table 1](#t1-asm-2-102){ref-type="table"}. Twenty-three of the 26 rifampin-resistant isolates were also resistant to isoniazid. Nineteen of 26 (73.1%) rifampin-resistant isolates contained between 6 and 11 copies of IS*6110*. As shown in [Table 1](#t1-asm-2-102){ref-type="table"}, 18 different IS*6110* DNA fingerprint patterns were observed in the 26 rifampin-resistant isolates. Of the 18 patterns, five were shared by more than one isolate (a total of 13 isolates were in the cluster); the remaining 13 (50%) isolates gave unique fingerprinting patterns. IS*6110*-RFLP patterns of the isolates are shown in [Figure 1](#f1-asm-2-102){ref-type="fig"}. Four isolates with identical two copies of IS6110 were found as clonally unrelated by the pTBN12 fingerprinting method. However, the two isolates with identical four copies of IS6110 were also in the same cluster by the pTBN12 probe. When both methods were evaluated together, the level of clustering was 34.6% in rifampin-resistant *M. tuberculosis* isolates. Twenty-one (80.8 %) different DNA fingerprinting profiles were determined and the average number of isolates per pattern was 1.23 (26/21).

Discussion
==========

The Aegean region in the western part of Turkey has about 8 million inhabitants. The social security system is mainly public and is financed through taxes. The standard of living is above average for Turkey. In this region, 8.2 % of the *M. tuberculosis* strains isolated between 1999 and 2001 were found to be resistant to rifampin. During the same period, the incidence of resistance to both rifampin and isoniazid was 6.8 %.[@b11-asm-2-102] Although the rate of multiple drug resistance is high, there is no published data based on molecular methods concerning the transmission rate of drug-resistant strains in this region.

In the present study, seven of the rifampin-resistant *M. tuberculosis* isolates (4, 34 and 37; 6 and 9; 14 and 25) that had identical banding patterns also had the same rifampin-resistance genotypes described in our previous report[@b7-asm-2-102] ([Table 1](#t1-asm-2-102){ref-type="table"}). However two isolates (15 and 32) with the same IS*6110*-RFLP pattern had different rifampin-resistance genotypes. Isolates 4, 34, and 37 had a mutation CAC to CGC at codon 526. The patient data could not be obtained for isolate 4. However, it was determined that isolates 34 and 37 were obtained from patients living in the same town. Although isolates 6 and 9 were obtained from patients living in different areas, they had the same rifampin-resistance genotype (TCG to TTG at codon 531). Isolates 15 and 32 had the same banding pattern, but their resistance genotypes were different, and therefore, they may have had a low probability of being directly linked epidemiologically and due to recent transmission. It is more probable that the patients who shared the same fingerprinting pattern without a direct epidemiological link acquired their infection from the previous source case(s) that was (were) not included in the current study. The clustering in these patients may have resulted from ongoing rather than recent transmission.

When both typing methods were evaluated together the level of clustering was 34.6% and the average number of isolates per pattern was 1.23 (26/21). A relatively low level of DNA polymorphism and high level of clustering were also described in other studies in regions with a high level of TB transmission between patients.[@b12-asm-2-102]--[@b14-asm-2-102]

In conclusion, although a limited numbers of isolates were evaluated in this study, there were high levels of clustering in drug-resistant *M. tuberculosis* strains in our region. Therefore, we demonstrated that active transmission of drug-resistant *M. tuberculosis* strains may be common among patients in our region and urgent measures should be taken to prevent the spread of resistant strains. Molecular typing of *M. tuberculosis* strains may add information about the epidemiological situation and may also be used in surveying pandemics of TB. However, molecular typing results should always be evaluated with conventional epidemiological data.
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The IS*6110*-RFLP patterns and genotypic and phenotypic characteristics of RIF-resistant *M. tuberculosis* isolates from Aegean region

  IS6110-RFLP patterns                           Isolate no                                     IS*6110* copy number   Resistance genotype   Resistance phenotype
  ---------------------------------------------- ---------------------------------------------- ---------------------- --------------------- ----------------------
  1                                              4                                              10                     526 CAC CGC           RIF/INH/STR
  34                                             10                                             526 CAC CGC            RIF/INH/STR/EMB       
  37                                             10                                             526 CAC CGC            RIF/INH/STR/EMB       
                                                                                                                                             
  2                                              6                                              11                     531 TCG TTG           RIF/INH/STR
  9                                              11                                             531 TCG TTG            RIF/INH/STR/EMB       
                                                                                                                                             
  3                                              14[\*](#tfn2-asm-2-102){ref-type="table-fn"}   4                      531 TCG TTG           RIF/INH/STR
  25[\*](#tfn2-asm-2-102){ref-type="table-fn"}   4                                              531 TCG TTG            RIF/INH/STR           
                                                                                                                                             
  4                                              15                                             9                      526 CAC GAC           RIF/INH/STR
  32                                             9                                              531 TCG TGG            RIF/INH/STR/EMB       
                                                                                                                                             
  5                                              3[\*](#tfn2-asm-2-102){ref-type="table-fn"}    2                      531 TCG TTG           RIF/INH/STR
  29[\*](#tfn2-asm-2-102){ref-type="table-fn"}   2                                              531 TCG TTG            RIF/INH               
  30[\*](#tfn2-asm-2-102){ref-type="table-fn"}   2                                              522 TCG TGG            RIF/INH/STR           
  35[\*](#tfn2-asm-2-102){ref-type="table-fn"}   2                                              531 TCG TTG            RIF                   
                                                                                                                                             
  6                                              26[\*](#tfn2-asm-2-102){ref-type="table-fn"}   5                      526 CAC TAC           RIF/INH/STR/EMB
                                                                                                                                             
  7                                              8                                              9                      531 TCG TGG           RIF/EMB
                                                                                                                                             
  8                                              28                                             9                      533 CTG CCG           RIF
                                                                                                                                             
  9                                              43                                             9                      516 GAC TAC           RIF/INH/STR/EMB
                                                                                                                                             
  10                                             44                                             9                      531 TCG TTG           RIF/INH/EMB
                                                                                                                                             
  11                                             19                                             10                     513 CAA CCA           RIF/INH
                                                                                                                                             
  12                                             40                                             10                     531 TCG TTG           RIF/INH/STR/EMB
                                                                                                                                             
  13                                             50                                             10                     531 TCG TTG           RIF/INH/STR
                                                                                                                                             
  14                                             7                                              11                     531 TCG TTG           RIF/INH
                                                                                                                                             
  15                                             24                                             11                     531 TCG TTG           RIF/INH
                                                                                                                                             
  16                                             27                                             11                     526 CAC TGC           RIF/INH
                                                                                                                                             
  17                                             31                                             11                     531 TCG TTG           RIF/INH/STR
                                                                                                                                             
  18                                             45                                             11                     516 GAC GTC           RIF/INH/STR/EMB

RIF: rifampin, INH: isoniazid, STR: streptomycin, EMB: ethambutol

Isolates with a copy number fewer than six were also typed by pTBN12-RFLP
